New PATHFINDER Study Analysis Demonstrates Efficient Diagnostic Resolution Following Multi-Cancer Early Detection Testing

Diagnostic Evaluations Were Consistent With GalleriⓇ-Predicted Cancer Signal Origin in 78% of Study Participants Whole-Body Imaging Did Not Contribute to Di ...

Related Keywords

Menlo ,Washington ,United States ,North Carolina ,United Kingdom ,New York ,American ,Eric Klein ,Deb Schrag ,Trish Rowland ,Kristen Davis ,Kidney Institute ,Clinical Laboratory Improvement Amendments ,Illumina Inc ,European Society For Medical Oncology ,Order Of The European Commission ,American Society Of Clinical Oncology ,Corporate Communications ,Nasdaq ,College Of American Pathologists ,Drug Administration ,Laboratory Test Information ,Diagnostic Evaluations Were Consistent With ,Predicted Cancer Signal Origin ,Body Imaging Did Not Contribute ,Diagnostic Resolution ,More Than Half ,Were Presented ,Clinical Oncology ,Memorial Sloan Kettering Cancer Center ,Distinguished Scientist ,Glickman Urological ,Investigational Device Exemption ,European Society ,Medical Oncology ,Menlo Park ,Interim Measures Order ,Signal Not ,